Theratechnologies inc.

Theratechnologies inc.

December 04, 2006 14:12 ET

Theratechnologies to Present at BMO Capital Markets Focus on Healthcare Conference in New York

MONTREAL, QUEBEC--(CCNMatthews - Dec. 4, 2006) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer, will present a corporate update at the 6th annual Focus on Healthcare Conference hosted by BMO Capital Markets at 9:00 am on Wednesday, December 6, 2006, at the Millennium Broadway Hotel in New York City.

A webcast of the presentation will be available simultaneously at the following address :

The presentation will also be archived for further reference.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets. The most advanced program is TH9507 in Phase 3 clinical development in HIV-associated lipodystrophy. The Company also has other promising projects at various stages of development.

Contact Information